Syneos Health completed the acquisition of Persol Pharma.

Synopsis

Syneos Health, a biopharmaceutical solutions organization, completed the acquisition of Persol Pharma, a clinical development assistance provider. Financial terms were not dislcosed.

Principals

target

Persol Pharma Partners

bidder

Syneos Health

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

latham & watkins

HQ - New York, United States

legal advisors

bidder

5443

Deals

£ 3,504.27 B

Total Value